Capital Allocation

Industrial conglomerate Schouw & Co. offers a fee for bondholder consent to spin off its aquaculture giant BioMar, a move that could unlock value but alters risk.

A new partnership between Finloop and EX.IO aims to build a compliant RWA ecosystem in Hong Kong, unlocking global liquidity for professional investors.

With its Q4 results announcement imminent, specialty insurer Trisura is under scrutiny to prove it can sustain growth amid market pressures and investor concerns.

Amid financial headwinds, specialty chemicals firm Orion S.A. will pitch its strategic pivot to the high-growth EV and sustainable materials markets.

As Vinci Compass preps its full-year 2025 results, investors watch for signs of strength in Latin America's burgeoning alternative asset market.

As Churchill Capital XI's shares and warrants begin separate trading, what does this mean for investors and the hunt for Michael Klein's next big deal?

With a new focus on eye disease and fresh funding, Surrozen will present its novel Wnt-based pipeline to investors. What's at stake for the future of sight?

Veteran investor Stephen Riddell partners with Gallatin Point to launch DS2 Capital, a new firm poised to navigate the complex structured credit market.

A new report reveals a stark drop in profitability, but owners remain surprisingly optimistic, fueling a massive surge in demand for capital.

In a volatile market, NASIS founder Karen Kennedy shares a crisis-forged blueprint for disciplined investing and avoiding the perils of herd mentality.

A new report reveals a looming crisis: rising healthcare costs will consume more than 100% of Social Security benefits for future generations of retirees.

A record $1M transaction on Bitcoin's Lightning Network proves it's ready for institutional finance, challenging old systems with near-instant settlement.

Barrick Mining unveils a massive dividend hike and a new cash-return policy, but a surprising market dip raises questions about its future outlook.

The semiconductor giant posted a huge Non-GAAP profit but a stunning IFRS loss for 2025. What's behind the numbers and why are investors cheering?

Forum Energy Technologies has extended its $250M credit facility to 2031, a move that strengthens its balance sheet and fuels its 'FET 2030' growth plans.

Mount Logan Capital's tender offer was met with high demand, leading to a planned 12% reduction in shares and boosting key per-share metrics.

Life sciences giant QIAGEN defies economic headwinds with strong 2025 results, signaling aggressive growth in single-cell analysis and bioinformatics.

The insurance giant beat adjusted earnings estimates on strong operational performance, even as derivative losses weighed on its reported GAAP revenue.

Amid strong revenue growth, Capstone's focus on powering AI and datacenters takes center stage as investors await crucial Q3 financial results.

As EQB prepares to release its Q1 2026 results, investors are watching to see if its digital strategy and PC Financial deal can fuel a rebound.